×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions by Pushkal Garg

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
ALNYALNYLAM PHARMACEUTICALS, INC.Pushkal GargEVP Chief R&DAug 18, 2025Sale$453.271,396632,75923,033Aug 19, 2025, 05:28 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Pushkal GargEVP Chief R&DAug 19, 2025Sale$458.411,455666,98721,400Aug 19, 2025, 05:28 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Pushkal GargCMO & EVP Dev & Med AffairsMar 24, 2025Sale$300.005,4451,633,50020,221Mar 25, 2025, 04:10 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Pushkal GargCMO & EVP Dev & Med AffairsMar 21, 2025Sale$285.004,3211,231,48520,221Mar 25, 2025, 04:10 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Pushkal GargCMO & EVP Dev & Med AffairsMar 24, 2025Option/RSU Exercise$42.225,445229,88825,666Mar 25, 2025, 04:10 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Pushkal GargCMO & EVP Dev & Med AffairsFeb 27, 2025Option/RSU Exercise-1,908-13,897Mar 03, 2025, 04:31 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Pushkal GargCMO & EVP Dev & Med AffairsFeb 28, 2025Sale$241.69935225,97713,846Mar 03, 2025, 04:31 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Pushkal GargCMO & EVP Dev & Med AffairsFeb 18, 2025Sale$251.671,548389,57912,675Feb 18, 2025, 04:47 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Pushkal GargCMO & EVP Dev & Med AffairsFeb 14, 2025Sale$255.171,561398,32514,749Feb 18, 2025, 04:47 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Pushkal GargCMO & EVP Dev & Med AffairsJan 27, 2025Option/RSU Exercise$88.9548,8764,347,52064,581Jan 29, 2025, 04:03 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Pushkal GargCMO & EVP Dev & Med AffairsJan 27, 2025Sale$285.0052,59214,988,72011,989Jan 29, 2025, 04:03 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Pushkal GargCMO & EVP Dev & Med AffairsDec 12, 2024Sale$251.001,752439,76017,336Dec 13, 2024, 04:13 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Pushkal GargCMO & EVP Dev & Med AffairsNov 26, 2024Sale$250.981,682422,14419,109Nov 27, 2024, 05:22 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Pushkal GargCMO & EVP Dev & Med AffairsJun 25, 2024Sale$230.992,103485,77317,634Jun 26, 2024, 04:28 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Pushkal GargCMO & EVP Dev & Med AffairsFeb 27, 2024Option/RSU Exercise-1,908-9,240Feb 29, 2024, 04:17 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Pushkal GargCMO & EVP Dev & Med AffairsFeb 28, 2024Sale$155.3057489,1458,993Feb 29, 2024, 04:17 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Pushkal GargCMO & EVP Dev & Med AffairsFeb 16, 2024Sale$148.061,308193,6668,160Feb 20, 2024, 04:09 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Pushkal GargCMO & EVP Dev & Med AffairsAug 04, 2023Sale$185.853,461643,22311,314Aug 07, 2023, 06:05 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Pushkal GargCMO & EVP Dev & Med AffairsAug 07, 2023Sale$183.894,166766,0835,399Aug 07, 2023, 06:05 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Pushkal GargCMO & EVP Dev & Med AffairsApr 27, 2023Sale$194.591,839357,8558,488Apr 28, 2023, 05:54 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Pushkal GargCMO & EVP Dev & Med AffairsApr 28, 2023Sale$199.022,455488,5956,596Apr 28, 2023, 05:54 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Pushkal GargCMO & EVP Dev & Med AffairsMar 03, 2023Option/RSU Exercise$96.455,000482,25022,417Mar 07, 2023, 04:07 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Pushkal GargCMO & EVP Dev & Med AffairsMar 03, 2023Sale$200.0018,0723,614,4004,345Mar 07, 2023, 04:07 PM
ALNYALNYLAM PHARMACEUTICALS, INC.Pushkal GargCMO & EVP Dev & Med AffairsAug 04, 2022Tax Payment (Shares)$191.555,086974,20117,900Aug 05, 2022, 04:14 PM